Comparing Sensus Healthcare (SRTS) & Its Rivals

Sensus Healthcare (NASDAQ:SRTS) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its peers? We will compare Sensus Healthcare to similar businesses based on the strength of its risk, institutional ownership, profitability, dividends, earnings, analyst recommendations and valuation.

Valuation & Earnings

This table compares Sensus Healthcare and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Sensus Healthcare	$27.48 million	-$7.72 million	-2.94
Sensus Healthcare Competitors	$1.89 billion	$137.77 million	9.62

Sensus Healthcare’s peers have higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 10.2% of Sensus Healthcare shares are owned by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Sensus Healthcare and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sensus Healthcare	-88.45%	-21.57%	-19.20%
Sensus Healthcare Competitors	-276.78%	-149.08%	-21.73%

Analyst Ratings

This is a summary of current ratings and recommmendations for Sensus Healthcare and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sensus Healthcare	1	0	4	0	2.60
Sensus Healthcare Competitors	4270	10535	18300	828	2.46

Sensus Healthcare currently has a consensus price target of $5.83, suggesting a potential upside of 111.35%. As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.16%. Given Sensus Healthcare’s stronger consensus rating and higher probable upside, analysts clearly believe Sensus Healthcare is more favorable than its peers.

Volatility & Risk

Sensus Healthcare has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Sensus Healthcare’s peers have a beta of 2.57, indicating that their average stock price is 157% more volatile than the S&P 500.

Summary

Sensus Healthcare peers beat Sensus Healthcare on 7 of the 13 factors compared.

About Sensus Healthcare

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.